Invention Grant
- Patent Title: Multiple transgene recombinant adenovirus
-
Application No.: US16604675Application Date: 2018-04-12
-
Publication No.: US12036247B2Publication Date: 2024-07-16
- Inventor: Tony R. Reid , Christopher Larson , Bryan T. Oronsky
- Applicant: EpicentRx, Inc.
- Applicant Address: US CA La Jolla
- Assignee: EPICENTRX, INC.
- Current Assignee: EPICENTRX, INC.
- Current Assignee Address: US CA La Jolla
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2018/027375 2018.04.12
- International Announcement: WO2018/191545A 2018.10.18
- Date entered country: 2019-10-11
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K35/74 ; A61K35/768 ; A61K48/00 ; C07K14/54 ; C12N9/64 ; C12N15/86 ; C12N15/861
Abstract:
The invention relates to a recombinant adenovirus comprising two or more therapeutic transgenes, e.g., two components of a heterodimeric cytokine, separated by a cleavable linker.
Public/Granted literature
- US20200078415A1 MULTIPLE TRANSGENE RECOMBINANT ADENOVIRUS Public/Granted day:2020-03-12
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
